Medication development for the treatment of cocaine dependence: issues in clinical efficacy trials

Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research

Overview of potential treatment medications for cocaine dependence

Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective

Management of clinical trials with new medications for cocaine dependence and abuse

Outcome measurement considerations: pharmacological treatments for substance abuse

Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials

Baseline assessment, study entry, and stabilization: double-blind clinical trials in drug dependence

Addiction severity index in clinical efficacy trials of medications for cocaine dependence

Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment

Treatment effectiveness score as an outcome measure in clinical trials

Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis

Quantitative urine levels of cocaine and other substances of abuse

Use of quantitative urinalysis in monitoring cocaine use

Is quantitative urinalysis more sensitive?

Comparison of immunoassays for semiquantitative measurement of benzoylecgonine in urine

Appendix I: Workshop summary outcome measures and success criteria

Appendix II: Workshop summary clinical decision tree for cocaine addiction pharmacotherapy.